concentra, pharma, pricing, market access, data, visualisation

Download: Top 5 Pricing and Market Access Visualisations every pharmaceutical organisation needs

Analytics is a hot topic in pharmaceuticals and life sciences. Data visualisation is unlocking new understanding and value at all stages of the product lifecycle. Once the territory of the research and development process, big data analytics is now becoming the differentiator in commercial and operational decision making. How can you get the most out of your pricing and market …

Prescription drugs on sale online in China

With China Food and Drug Administration (CFDA)’s recently introduced policy, the Chinese can now potentially purchase their prescription drugs online at Walmart or even Alibaba.com. Though the final list of available prescription drugs are to be consolidated over the next couple of days, this new policy seems to have sparked a discussion amongst China and the region. If prescription drugs, …

The Netherlands: In the midst of change

  At the World Pharma Pricing & Market Access Congress 2014 conference, Dr Martin van der Graaff, Secretary, Reimbursement Committee, CVZ gave the presentation: “The Netherlands: In the mi(d)st of change” Download and learn: Organisational change in CVZ End of an era: Policy rules and outcomes research First results and experiences with CED Preliminary criteria for prioritizing inpatient drugs Priorities Are …

Download: Impact of 2012 Presidential Election and US Healthcare Reform

  With just over a month to go until Pharma Pricing and Market Access Outlook World Europe 2014, the worlds largest gathering of pharmaceutical pricing, market access and reimbursement professionals, we though that we would relive one of the highlights of last year’s event. During the 2013 conference, Saira A. Jan, M.S., Pharm.D. gave a joint presentation entitled “Impact of …

Utilizing Global Pricing Data and Advanced Analytics for Better Decisions and Competitor Edge

By Preeti Patel, VP, Consulting Increasing price transparency and global competition are key challenges faced by companies across all industries. Today’s pricing decisions cannot be based on instinct or informal methods due to the high level of risk incurred through inaccurate practices. Data and analytics have become powerful tools for pharmaceutical organizations in their strive to stay ahead of competitors. …

The role of technology in driving productivity and harnessing lost revenue

by James Robinson, Director of Solutions, Model N As with other markets, the Life Sciences industry has not escaped the effects of the global economic downturn, with the supplier/customer relationship undergoing radical change. Add to this the impact of changing regulation regarding patent protection, for example, and manufacturers are having to come to terms with a very different competitive environment …

Download: Three Vital Areas for Improving Market Access – for Industry & Payers

  Last year's Pharma Pricing & Market Access Europe included discussions on key topics including: maneuvering changes in the healthcare environment, pricing & market access in the major international markets, and patient access and flexible pricing schemes. One particularly notable presentation was given by Colin Wight, Chief Executive of GalbraithWight, entitled “Three Vital Areas for Improving Market Access – for …

Download: Scarcity, value and price

Pharma Pricing & Market Access Europe 2013 addressed the critical policy issues in developing the optimum pricing strategy for pharmaceutical products last March.  Discussions revolved around topics involving policy challenges in market access, HTA practice effecting the market, and how innovative pricing and risk sharing models between industry and payers have changed. At the event, Jim Furniss, Senior VP, Market …

Maximise revenue and optimise pricing in an outcomes-based world

  At Pharma Pricing & Market Access Europe 2013, Sophie Murdoch, VP, ALSCG gave a presentation entitled “Maximise revenue and optimise pricing in an outcomes-based world.” Download the presentation and learn: Market access simply defined Compromises of access Market access performance improvement A 5 step guide to making more effective decisions Download presentation The 8th Annual Pharma Pricing and Market …